These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 21479696

  • 1. Bortezomib-based chemotherapy for light chain deposition disease presenting as acute renal failure.
    Gharwan H, Truica CI.
    Med Oncol; 2012 Jun; 29(2):1197-201. PubMed ID: 21479696
    [Abstract] [Full Text] [Related]

  • 2. Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.
    Hada R, Poudyal B, Sharma A, Khatri R.
    JNMA J Nepal Med Assoc; 2012 Jun; 52(188):192-5. PubMed ID: 23591252
    [Abstract] [Full Text] [Related]

  • 3. Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.
    Kaposztas Z, Kahan BD, Katz SM, Van Buren CT, Cherem L.
    Transplant Proc; 2009 Dec; 41(10):4407-10. PubMed ID: 20005409
    [Abstract] [Full Text] [Related]

  • 4. Light chain deposition disease affecting the gastrointestinal tract in the setting of post-living donor kidney transplantation.
    Jimenez-Zepeda VH, Vajpeyi R, John R, Trudel S.
    Int J Hematol; 2012 Jul; 96(1):125-31. PubMed ID: 22573235
    [Abstract] [Full Text] [Related]

  • 5. Bortezomib-dexamethasone combination in a patient with refractory multiple myeloma and impaired renal function.
    Nozza A, Siracusano L, Armando S.
    Clin Ther; 2006 Jun; 28(6):953-9. PubMed ID: 16860177
    [Abstract] [Full Text] [Related]

  • 6. Induction treatment of light chain deposition disease with bortezomib: rapid hematological response with persistence of renal involvement.
    Minarik J, Scudla V, Tichy T, Pika T, Bacovsky J, Lochman P, Zadrazil J.
    Leuk Lymphoma; 2012 Feb; 53(2):330-1. PubMed ID: 21883030
    [No Abstract] [Full Text] [Related]

  • 7. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK, Yang AH, Lai HC, Lin BS.
    BMC Nephrol; 2017 May 25; 18(1):170. PubMed ID: 28545410
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Improved prognosis in light chain nephropathy due to multiple myeloma].
    Juul JS, Larsen T, Marcussen N, Pedersen EB.
    Ugeskr Laeger; 2012 Apr 23; 174(17):1159-60. PubMed ID: 22533933
    [Abstract] [Full Text] [Related]

  • 10. The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.
    Talbot B, Wright D, Basnayake K.
    BMJ Case Rep; 2014 Oct 17; 2014():. PubMed ID: 25326567
    [Abstract] [Full Text] [Related]

  • 11. Bortezomib-based therapy combined with high cut-off hemodialysis is highly effective in newly diagnosed multiple myeloma patients with severe renal impairment.
    Zannetti BA, Zamagni E, Santostefano M, De Sanctis LB, Tacchetti P, Mancini E, Pantani L, Brioli A, Rizzo R, Mancuso K, Rocchi S, Pezzi A, Borsi E, Terragna C, Marzocchi G, Santoro A, Cavo M.
    Am J Hematol; 2015 Jul 17; 90(7):647-52. PubMed ID: 25858483
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V, Mijušković Z, Marjanović S, Rabrenović M, Jovanović D, Antić S, Ignjatović L, Petrović M, Pilcević D.
    Vojnosanit Pregl; 2015 Feb 17; 72(2):196-9. PubMed ID: 25831916
    [Abstract] [Full Text] [Related]

  • 15. Best treatment strategies in high-risk multiple myeloma: navigating a gray area.
    Bianchi G, Richardson PG, Anderson KC.
    J Clin Oncol; 2014 Jul 10; 32(20):2125-32. PubMed ID: 24888801
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
    Grannis CH, Dewan VN, Wang RC.
    Retin Cases Brief Rep; 2014 Jul 10; 8(4):348-51. PubMed ID: 25372546
    [Abstract] [Full Text] [Related]

  • 20. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F, Delbes S, Sirac C, Pourreau F, Puyade M, Desport E, Jaccard A, Fermand JP, Touchard G.
    Presse Med; 2012 Mar 10; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.